FDA Inspection
Alembic Pharmaceuticals Limited (Units I and II)Alembic Pharmaceuticals Limited (Units I and II) – FDA Inspection, May 31, 2025
Record Details
This FDA Inspection record concerns Alembic Pharmaceuticals Limited (Units I and II), with an inspection on May 31, 2025, issued by the Office of Inspections and Investigations, covering human drugs.
- Inspection Date
- May 31, 2025
- Product Type
- Human Drugs
View Company Profile
ID · ba9076d1-2082-46d5-bc86-a9f09fe8f8d6
Inspection Facts
- Inspection number
- 1270216
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Alembic Pharmaceuticals Limited (Units I and II)
8| Date | Classification | Office | Project area |
|---|---|---|---|
| October 8, 2024 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| December 19, 2018 | Not classified | Office of Inspections and Investigations | |
| April 23, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 29, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 18, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Alembic Pharmaceuticals Limited (Units I and II)
- FDA Inspection 1249881 - 2024-10-08
- FDA Inspection 1076862 - 2018-12-19
- FDA Inspection 1055013 - 2018-04-23
- FDA Inspection 982077 - 2016-06-29
- FDA Inspection 831397 - 2013-04-18
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.